In-Vivo Efficacy of Chloroquine to Clear Asymptomatic Infections in Mozambican Adults: A Randomized, Placebo-controlled Trial with Implications for Elimination Strategies
Abstract Recent reports regarding the re-emergence of parasite sensitivity to chloroquine call for a new consideration of this drug as an interesting complementary tool in malaria elimination efforts, given its good safety profile and long half-life. A randomized (2:1), single-blind, placebo-control...
Guardado en:
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6bfb991774b04f97b3e7944417ea6562 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:6bfb991774b04f97b3e7944417ea6562 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:6bfb991774b04f97b3e7944417ea65622021-12-02T16:06:25ZIn-Vivo Efficacy of Chloroquine to Clear Asymptomatic Infections in Mozambican Adults: A Randomized, Placebo-controlled Trial with Implications for Elimination Strategies10.1038/s41598-017-01365-42045-2322https://doaj.org/article/6bfb991774b04f97b3e7944417ea65622017-05-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-01365-4https://doaj.org/toc/2045-2322Abstract Recent reports regarding the re-emergence of parasite sensitivity to chloroquine call for a new consideration of this drug as an interesting complementary tool in malaria elimination efforts, given its good safety profile and long half-life. A randomized (2:1), single-blind, placebo-controlled trial was conducted in Manhiça, Mozambique, to assess the in-vivo efficacy of chloroquine to clear plasmodium falciparum (Pf) asymptomatic infections. Primary study endpoint was the rate of adequate and parasitological response (ACPR) to therapy on day 28 (PCR-corrected). Day 0 isolates were analyzed to assess the presence of the PfCRT-76T CQ resistance marker. A total of 52 and 27 male adults were included in the CQ and Placebo group respectively. PCR-corrected ACPR was significantly higher in the CQ arm 89.4% (95%CI 80–98%) compared to the placebo (p < 0.001). CQ cleared 49/50 infections within the first 72 h while placebo cleared 12/26 (LRT p < 0.001). The PfCRT-76T mutation was present only in one out of 108 (0.9%) samples at baseline, well below the 84% prevalence found in 1999 in the same area. This study presents preliminary evidence of a return of chloroquine sensitivity in Mozambican Pf isolates, and calls for its further evaluation in community-based malaria elimination efforts, in combination with other effective anti-malarials. Trial registration: www.clinicalTrials.gov NCT02698748.Beatriz GalatasLidia NhamussuaBaltazar CandrinhoLurdes MabotePau CisteróHimanshu GuptaRegina RabinovichClara MenéndezEusebio MaceteFrancisco SauteAlfredo MayorPedro AlonsoQuique BassatPedro AideNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-10 (2017) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Beatriz Galatas Lidia Nhamussua Baltazar Candrinho Lurdes Mabote Pau Cisteró Himanshu Gupta Regina Rabinovich Clara Menéndez Eusebio Macete Francisco Saute Alfredo Mayor Pedro Alonso Quique Bassat Pedro Aide In-Vivo Efficacy of Chloroquine to Clear Asymptomatic Infections in Mozambican Adults: A Randomized, Placebo-controlled Trial with Implications for Elimination Strategies |
description |
Abstract Recent reports regarding the re-emergence of parasite sensitivity to chloroquine call for a new consideration of this drug as an interesting complementary tool in malaria elimination efforts, given its good safety profile and long half-life. A randomized (2:1), single-blind, placebo-controlled trial was conducted in Manhiça, Mozambique, to assess the in-vivo efficacy of chloroquine to clear plasmodium falciparum (Pf) asymptomatic infections. Primary study endpoint was the rate of adequate and parasitological response (ACPR) to therapy on day 28 (PCR-corrected). Day 0 isolates were analyzed to assess the presence of the PfCRT-76T CQ resistance marker. A total of 52 and 27 male adults were included in the CQ and Placebo group respectively. PCR-corrected ACPR was significantly higher in the CQ arm 89.4% (95%CI 80–98%) compared to the placebo (p < 0.001). CQ cleared 49/50 infections within the first 72 h while placebo cleared 12/26 (LRT p < 0.001). The PfCRT-76T mutation was present only in one out of 108 (0.9%) samples at baseline, well below the 84% prevalence found in 1999 in the same area. This study presents preliminary evidence of a return of chloroquine sensitivity in Mozambican Pf isolates, and calls for its further evaluation in community-based malaria elimination efforts, in combination with other effective anti-malarials. Trial registration: www.clinicalTrials.gov NCT02698748. |
format |
article |
author |
Beatriz Galatas Lidia Nhamussua Baltazar Candrinho Lurdes Mabote Pau Cisteró Himanshu Gupta Regina Rabinovich Clara Menéndez Eusebio Macete Francisco Saute Alfredo Mayor Pedro Alonso Quique Bassat Pedro Aide |
author_facet |
Beatriz Galatas Lidia Nhamussua Baltazar Candrinho Lurdes Mabote Pau Cisteró Himanshu Gupta Regina Rabinovich Clara Menéndez Eusebio Macete Francisco Saute Alfredo Mayor Pedro Alonso Quique Bassat Pedro Aide |
author_sort |
Beatriz Galatas |
title |
In-Vivo Efficacy of Chloroquine to Clear Asymptomatic Infections in Mozambican Adults: A Randomized, Placebo-controlled Trial with Implications for Elimination Strategies |
title_short |
In-Vivo Efficacy of Chloroquine to Clear Asymptomatic Infections in Mozambican Adults: A Randomized, Placebo-controlled Trial with Implications for Elimination Strategies |
title_full |
In-Vivo Efficacy of Chloroquine to Clear Asymptomatic Infections in Mozambican Adults: A Randomized, Placebo-controlled Trial with Implications for Elimination Strategies |
title_fullStr |
In-Vivo Efficacy of Chloroquine to Clear Asymptomatic Infections in Mozambican Adults: A Randomized, Placebo-controlled Trial with Implications for Elimination Strategies |
title_full_unstemmed |
In-Vivo Efficacy of Chloroquine to Clear Asymptomatic Infections in Mozambican Adults: A Randomized, Placebo-controlled Trial with Implications for Elimination Strategies |
title_sort |
in-vivo efficacy of chloroquine to clear asymptomatic infections in mozambican adults: a randomized, placebo-controlled trial with implications for elimination strategies |
publisher |
Nature Portfolio |
publishDate |
2017 |
url |
https://doaj.org/article/6bfb991774b04f97b3e7944417ea6562 |
work_keys_str_mv |
AT beatrizgalatas invivoefficacyofchloroquinetoclearasymptomaticinfectionsinmozambicanadultsarandomizedplacebocontrolledtrialwithimplicationsforeliminationstrategies AT lidianhamussua invivoefficacyofchloroquinetoclearasymptomaticinfectionsinmozambicanadultsarandomizedplacebocontrolledtrialwithimplicationsforeliminationstrategies AT baltazarcandrinho invivoefficacyofchloroquinetoclearasymptomaticinfectionsinmozambicanadultsarandomizedplacebocontrolledtrialwithimplicationsforeliminationstrategies AT lurdesmabote invivoefficacyofchloroquinetoclearasymptomaticinfectionsinmozambicanadultsarandomizedplacebocontrolledtrialwithimplicationsforeliminationstrategies AT paucistero invivoefficacyofchloroquinetoclearasymptomaticinfectionsinmozambicanadultsarandomizedplacebocontrolledtrialwithimplicationsforeliminationstrategies AT himanshugupta invivoefficacyofchloroquinetoclearasymptomaticinfectionsinmozambicanadultsarandomizedplacebocontrolledtrialwithimplicationsforeliminationstrategies AT reginarabinovich invivoefficacyofchloroquinetoclearasymptomaticinfectionsinmozambicanadultsarandomizedplacebocontrolledtrialwithimplicationsforeliminationstrategies AT claramenendez invivoefficacyofchloroquinetoclearasymptomaticinfectionsinmozambicanadultsarandomizedplacebocontrolledtrialwithimplicationsforeliminationstrategies AT eusebiomacete invivoefficacyofchloroquinetoclearasymptomaticinfectionsinmozambicanadultsarandomizedplacebocontrolledtrialwithimplicationsforeliminationstrategies AT franciscosaute invivoefficacyofchloroquinetoclearasymptomaticinfectionsinmozambicanadultsarandomizedplacebocontrolledtrialwithimplicationsforeliminationstrategies AT alfredomayor invivoefficacyofchloroquinetoclearasymptomaticinfectionsinmozambicanadultsarandomizedplacebocontrolledtrialwithimplicationsforeliminationstrategies AT pedroalonso invivoefficacyofchloroquinetoclearasymptomaticinfectionsinmozambicanadultsarandomizedplacebocontrolledtrialwithimplicationsforeliminationstrategies AT quiquebassat invivoefficacyofchloroquinetoclearasymptomaticinfectionsinmozambicanadultsarandomizedplacebocontrolledtrialwithimplicationsforeliminationstrategies AT pedroaide invivoefficacyofchloroquinetoclearasymptomaticinfectionsinmozambicanadultsarandomizedplacebocontrolledtrialwithimplicationsforeliminationstrategies |
_version_ |
1718385030460342272 |